Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 282

1.

Evaluation of p16/Ki-67 dual stain cytology performed on self-collected vaginal and clinician-collected cervical specimens for the detection of cervical pre-cancer.

Toliman PJ, Phillips S, de Jong S, O'Neill T, Tan G, Brotherton JML, Saville M, Kaldor JM, Vallely AJ, Tabrizi SN.

Clin Microbiol Infect. 2019 Oct 22. pii: S1198-743X(19)30556-7. doi: 10.1016/j.cmi.2019.10.020. [Epub ahead of print]

PMID:
31654795
2.

Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014-2017.

Chow EPF, Tabrizi SN, Fairley CK, Wigan R, Machalek DA, Regan DG, Hocking JS, Garland SM, Cornall AM, Atchison S, Bradshaw CS, McNulty A, Owen L, Marshall L, Russell DB, Kaldor JM, Chen MY.

Vaccine. 2019 Oct 31;37(46):6907-6914. doi: 10.1016/j.vaccine.2019.09.052. Epub 2019 Sep 24.

PMID:
31562001
3.

Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial.

Chen MY, McNulty A, Avery A, Whiley D, Tabrizi SN, Hardy D, Das AF, Nenninger A, Fairley CK, Hocking JS, Bradshaw CS, Donovan B, Howden BP, Oldach D; Solitaire-U Team.

Lancet Infect Dis. 2019 Aug;19(8):833-842. doi: 10.1016/S1473-3099(19)30116-1. Epub 2019 Jun 10.

PMID:
31196813
4.

Gut microbiota of preterm infants supplemented with probiotics: sub-study of the ProPrems trial.

Plummer EL, Bulach DM, Murray GL, Jacobs SE, Tabrizi SN, Garland SM; ProPrems Study Group.

BMC Microbiol. 2018 Nov 13;18(1):184. doi: 10.1186/s12866-018-1326-1.

5.

Performance of clinical screening algorithms comprising point-of-care HPV-DNA testing using self-collected vaginal specimens, and visual inspection of the cervix with acetic acid, for the detection of underlying high-grade squamous intraepithelial lesions in Papua New Guinea.

Toliman PJ, Kaldor JM, Badman SG, Gabuzzi J, Silim S, Kumbia A, Kombuk B, Kombati Z, Munnull G, Guy R, Vallely LM, Kelly-Hanku A, Wand H, Ryan C, Tan G, Brotherton J, Saville M, Mola GDL, Garland SM, Tabrizi SN, Vallely AJ.

Papillomavirus Res. 2018 Dec;6:70-76. doi: 10.1016/j.pvr.2018.10.009. Epub 2018 Nov 1.

6.

Development of a rapid colorimetric multiplex PCR-reverse line blot for the detection and typing of 14 Chlamydia trachomatis genovars.

Molano M, Tabrizi SN, Phillips S, Danielewski J, Cornall A, Morre SA, Garland SM.

J Med Microbiol. 2018 Oct 10. doi: 10.1099/jmm.0.000836. [Epub ahead of print]

PMID:
30303481
7.

Molecular point-of-care testing for chlamydia and gonorrhoea in Indigenous Australians attending remote primary health services (TTANGO): a cluster-randomised, controlled, crossover trial.

Guy RJ, Ward J, Causer LM, Natoli L, Badman SG, Tangey A, Hengel B, Wand H, Whiley D, Tabrizi SN, Shephard M, Fairley CK, Donovan B, Anderson DA, Regan DG, Maher L, Kaldor JM.

Lancet Infect Dis. 2018 Oct;18(10):1117-1126. doi: 10.1016/S1473-3099(18)30429-8.

PMID:
30303108
8.

Development of a pilot proficiency program for human papillomavirus DNA detection.

Costa AG, Escott R, Garland SM, Byers D, Tabrizi SN.

Pathology. 2018 Oct;50(6):659-664. doi: 10.1016/j.pathol.2018.05.005. Epub 2018 Aug 20.

PMID:
30139535
9.

Detection of Chlamydia trachomatis mRNA using digital PCR as a more accurate marker of viable organism.

Phillips S, Vodstrcil LA, Huston WM, Lawerence A, Timms P, Chen MY, Worthington K, McIver R, Bradshaw CS, Garland SM, Tabrizi SN, Hocking JS.

Eur J Clin Microbiol Infect Dis. 2018 Nov;37(11):2117-2122. doi: 10.1007/s10096-018-3347-y. Epub 2018 Aug 14.

PMID:
30109584
10.

HLA and KIR Associations of Cervical Neoplasia.

Bao X, Hanson AL, Madeleine MM, Wang SS, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, Ohlsson C, Cortes A, Marshall M, Mukhopadhyay P, Cremin K, Johnson LG, Garland SM, Tabrizi SN, Wentzensen N, Sitas F, Trimble C, Little J, Cruickshank M, Frazer IH, Hildesheim A, Brown MA, Duncan EL, Sun YP, Leo PJ.

J Infect Dis. 2018 Nov 5;218(12):2006-2015. doi: 10.1093/infdis/jiy483.

11.

Cellular Immune Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent HPV Vaccine in Fijian Girls and Subsequent Responses to a Dose of Bivalent HPV Vaccine.

Toh ZQ, Cheow KWB, Russell FM, Hoe E, Reyburn R, Fong J, Tuivaga E, Ratu FT, Nguyen CD, Matanitobua S, Reitsma A, Tabrizi SN, Garland SM, Mulholland EK, Licciardi PV.

Open Forum Infect Dis. 2018 Jun 20;5(7):ofy147. doi: 10.1093/ofid/ofy147. eCollection 2018 Jul.

12.

Follow-up study of HPV58 variants in women with incident HPV58 infection from a Colombian cohort.

Molano M, Buitrago O, Moreno-Acosta P, Garland SM, Morales N, Huertas A, Martinez T, Gamboa O, Tabrizi SN, Cornall A, Muñoz N.

Oncol Lett. 2018 Aug;16(2):2511-2516. doi: 10.3892/ol.2018.8928. Epub 2018 Jun 8.

13.

Evaluation of self-collected vaginal specimens for the detection of high-risk human papillomavirus infection and the prediction of high-grade cervical intraepithelial lesions in a high-burden, low-resource setting.

Toliman PJ, Kaldor JM, Badman SG, Phillips S, Tan G, Brotherton JML, Saville M, Vallely AJ, Tabrizi SN.

Clin Microbiol Infect. 2019 Apr;25(4):496-503. doi: 10.1016/j.cmi.2018.05.025. Epub 2018 Jun 12.

PMID:
29906593
14.

Decline in prevalence of human papillomavirus infection following vaccination among Australian Indigenous women, a population at higher risk of cervical cancer: The VIP-I study.

McGregor S, Saulo D, Brotherton JML, Liu B, Phillips S, Skinner SR, Luey M, Oliver L, Stewart M, Tabrizi SN, Garland S, Kaldor JM.

Vaccine. 2018 Jul 5;36(29):4311-4316. doi: 10.1016/j.vaccine.2018.05.104. Epub 2018 Jun 5.

PMID:
29880245
15.

Molecular test for chlamydia and gonorrhoea used at point of care in remote primary healthcare settings: a diagnostic test evaluation.

Causer LM, Guy RJ, Tabrizi SN, Whiley DM, Speers DJ, Ward J, Tangey A, Badman SG, Hengel B, Natoli LJ, Anderson DA, Wand H, Wilson D, Regan DG, Shephard M, Donovan B, Fairley CK, Kaldor JM.

Sex Transm Infect. 2018 Aug;94(5):340-345. doi: 10.1136/sextrans-2017-053443. Epub 2018 May 10.

16.

Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program.

Garland SM, Cornall AM, Brotherton JML, Wark JD, Malloy MJ, Tabrizi SN; VACCINE study group.

Vaccine. 2018 May 31;36(23):3221-3230. doi: 10.1016/j.vaccine.2018.04.080. Epub 2018 Apr 30.

PMID:
29724506
17.

Correction: Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study.

Leo PJ, Madeleine MM, Wang S, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Hallmans G, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, Ohlsson C, Cortes A, Marshall M, Mukhopadhyay P, Cremin K, Johnson LG, Trimble CL, Garland S, Tabrizi SN, Wentzensen N, Sitas F, Little J, Cruickshank M, Frazer IH, Hildesheim A, Brown MA.

PLoS Genet. 2018 Mar 1;14(3):e1007257. doi: 10.1371/journal.pgen.1007257. eCollection 2018 Mar.

18.

Innovative approaches to cervical cancer screening in low- and middle-income countries.

Toliman PJ, Kaldor JM, Tabrizi SN, Vallely AJ.

Climacteric. 2018 Jun;21(3):235-238. doi: 10.1080/13697137.2018.1439917. Epub 2018 Feb 28. Review.

PMID:
29488817
19.

Very Low Prevalence of Vaccine Human Papillomavirus Types Among 18- to 35-Year Old Australian Women 9 Years Following Implementation of Vaccination.

Machalek DA, Garland SM, Brotherton JML, Bateson D, McNamee K, Stewart M, Rachel Skinner S, Liu B, Cornall AM, Kaldor JM, Tabrizi SN.

J Infect Dis. 2018 Apr 23;217(10):1590-1600. doi: 10.1093/infdis/jiy075.

PMID:
29425358
20.

Association between visual inspection of the cervix with acetic acid examination and high-risk human papillomavirus infection, Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in Papua New Guinea.

Vallely AJ, Toliman PJ, Ryan C, Rai G, Wapling J, Gabuzzi J, Kumbia A, Kombuk B, Kombati Z, Vallely LM, Kelly-Hanku A, Wand H, Tabrizi SN, Mola GDL, Kaldor JM.

Aust N Z J Obstet Gynaecol. 2018 Oct;58(5):576-581. doi: 10.1111/ajo.12783. Epub 2018 Jan 30.

PMID:
29380356
21.

Use of Pristinamycin for Macrolide-Resistant Mycoplasma genitalium Infection.

Read TRH, Jensen JS, Fairley CK, Grant M, Danielewski JA, Su J, Murray GL, Chow EPF, Worthington K, Garland SM, Tabrizi SN, Bradshaw CS.

Emerg Infect Dis. 2018 Feb;24(2):328-335. doi: 10.3201/eid2402.170902.

22.

A reliable and easy to transport quality control method for chlamydia and gonorrhoea molecular point of care testing.

Badman SG, Causer LM, Guy R, Wand H, Donovan B, Tabrizi SN, Speers D, Shephard MD, Vallely A, Whiley D; TTANGO investigators.

Pathology. 2018 Apr;50(3):317-321. doi: 10.1016/j.pathol.2017.09.012. Epub 2018 Jan 11.

PMID:
29336823
23.

Combined oral and topical antimicrobial therapy for male partners of women with bacterial vaginosis: Acceptability, tolerability and impact on the genital microbiota of couples - A pilot study.

Plummer EL, Vodstrcil LA, Danielewski JA, Murray GL, Fairley CK, Garland SM, Hocking JS, Tabrizi SN, Bradshaw CS.

PLoS One. 2018 Jan 2;13(1):e0190199. doi: 10.1371/journal.pone.0190199. eCollection 2018.

24.

HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples.

Cornall AM, Poljak M, Garland SM, Phillips S, Machalek DA, Tan JH, Quinn MA, Tabrizi SN.

Papillomavirus Res. 2017 Dec;4:79-84. doi: 10.1016/j.pvr.2017.10.002. Epub 2017 Oct 18.

25.

A Prospective Study of the Incidence of Juvenile-Onset Recurrent Respiratory Papillomatosis After Implementation of a National HPV Vaccination Program.

Novakovic D, Cheng ATL, Zurynski Y, Booy R, Walker PJ, Berkowitz R, Harrison H, Black R, Perry C, Vijayasekaran S, Wabnitz D, Burns H, Tabrizi SN, Garland SM, Elliott E, Brotherton JML.

J Infect Dis. 2018 Jan 4;217(2):208-212. doi: 10.1093/infdis/jix498.

PMID:
29136168
26.

Evaluation of the SpeeDx ResistancePlus MG Diagnostic Test for Mycoplasma genitalium on the Applied Biosystems 7500 Fast Quantitative PCR Platform.

Su JP, Tan LY, Garland SM, Tabrizi SN, Mokany E, Walker S, Bradshaw CS, Read T, Murray GL.

J Clin Microbiol. 2017 Dec 26;56(1). pii: e01245-17. doi: 10.1128/JCM.01245-17. Print 2018 Jan. No abstract available.

27.

Prevalence and risk factors associated with high-grade anal squamous intraepithelial lesions (HSIL)-AIN2 and HSIL-AIN3 in homosexual men.

Machalek DA, Jin F, Poynten IM, Hillman RJ, Templeton DJ, Law C, Roberts JM, Tabrizi SN, Garland SM, Farnsworth A, Fairley CK, Grulich AE; SPANC study team.

Papillomavirus Res. 2016 Dec;2:97-105. doi: 10.1016/j.pvr.2016.05.003. Epub 2016 May 24.

28.

Chlamydia Infection Between Men and Women: A Cross-Sectional Study of Heterosexual Partnerships.

Huffam S, Chow EPF, Leeyaphan C, Fairley CK, Hocking JS, Phillips S, Tabrizi SN, Bellhouse C, Bradshaw CS, Fehler G, Garland SM, Chen MY.

Open Forum Infect Dis. 2017 Sep 27;4(3):ofx160. doi: 10.1093/ofid/ofx160. eCollection 2017 Summer.

29.

Detection of human papillomavirus in urine among heterosexual men in relation to location of genital warts and circumcision status.

Aung ET, Fairley CK, Tabrizi SN, Danielewski JA, Ong JJ, Chen MY, Bradshaw CS, Chow EPF.

Sex Transm Infect. 2018 May;94(3):222-225. doi: 10.1136/sextrans-2016-053031. Epub 2017 Sep 2.

PMID:
28866637
30.

Defining the genetic susceptibility to cervical neoplasia-A genome-wide association study.

Leo PJ, Madeleine MM, Wang S, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Hallmans G, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, Ohlsson C, Cortes A, Marshall M, Mukhopadhyay P, Cremin K, Johnson LG, Trimble CL, Garland S, Tabrizi SN, Wentzensen N, Sitas F, Little J, Cruickshank M, Frazer IH, Hildesheim A, Brown MA.

PLoS Genet. 2017 Aug 14;13(8):e1006866. doi: 10.1371/journal.pgen.1006866. eCollection 2017 Aug. Erratum in: PLoS Genet. 2018 Mar 1;14 (3):e1007257.

31.

Vaccine-preventable anal human papillomavirus in Australian gay and bisexual men.

Poynten IM, Tabrizi SN, Jin F, Templeton DJ, Machalek DA, Cornall A, Phillips S, Fairley CK, Garland SM, Law C, Carr A, Hillman RJ, Grulich AE; SPANC Study Team.

Papillomavirus Res. 2017 Jun;3:80-84. doi: 10.1016/j.pvr.2017.02.003. Epub 2017 Feb 21.

32.

A case of acquired epidermodysplasia verruciformis in a renal transplant recipient clearing with multimodal treatment including HPV (Gardasil) vaccination.

Maor D, Brennand S, Goh MS, Fahey V, Tabrizi SN, Chong AH.

Australas J Dermatol. 2018 May;59(2):147-148. doi: 10.1111/ajd.12684. Epub 2017 Jul 17. No abstract available.

PMID:
28718200
33.

UriSwab: an effective transport medium for nucleic acid detection of Chlamydia trachomatis, Mycoplasma genitalium and Neisseria gonorrhoeae.

Costa AG, Garland SM, Guy R, Wand H, Tabrizi SN.

Sex Health. 2017 Nov;14(6):502-506. doi: 10.1071/SH16117.

PMID:
28697843
34.

Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.

Brotherton JML, Tabrizi SN, Phillips S, Pyman J, Cornall AM, Lambie N, Anderson L, Cummings M, Payton D, Scurry JP, Newman M, Sharma R, Saville M, Garland SM.

Int J Cancer. 2017 Oct 15;141(8):1576-1584. doi: 10.1002/ijc.30871. Epub 2017 Jul 14.

35.

A multicentre double-blind randomised controlled trial evaluating the efficacy of daily use of antibacterial mouthwash against oropharyngeal gonorrhoea among men who have sex with men: the OMEGA (Oral Mouthwash use to Eradicate GonorrhoeA) study protocol.

Chow EPF, Walker S, Hocking JS, Bradshaw CS, Chen MY, Tabrizi SN, Howden BP, Law MG, Maddaford K, Read TRH, Lewis DA, Whiley DM, Zhang L, Grulich AE, Kaldor JM, Cornelisse VJ, Phillips S, Donovan B, McNulty AM, Templeton DJ, Roth N, Moore R, Fairley CK.

BMC Infect Dis. 2017 Jun 28;17(1):456. doi: 10.1186/s12879-017-2541-3.

36.

Biological and Behavioral Factors Associated With Positive Chlamydia Retests.

Smith KS, Guy R, Danielewski J, Tabrizi SN, Fairley CK, McNulty AM, Rawlinson W, Saville M, Garland SM, Donovan B, Kaldor JM, Hocking JS; REACT investigators.

Sex Transm Dis. 2017 Jul;44(7):417-422. doi: 10.1097/OLQ.0000000000000616.

PMID:
28608791
37.

Contaminated fingers: a potential cause of Chlamydia trachomatis-positive urine specimens.

Giffard PM, Lilliebridge RA, Wilson J, Murray G, Phillips S, Tabrizi SN, Garland SM, Martin L, Singh G, Tong SYC, Holt DC, Andersson P.

Sex Transm Infect. 2018 Feb;94(1):32-36. doi: 10.1136/sextrans-2016-053081. Epub 2017 Jun 9.

38.

Measurement of tissue azithromycin levels in self-collected vaginal swabs post treatment using liquid chromatography and tandem mass spectrometry (LC-MS/MS).

Vodstrcil LA, Rupasinghe TWT, Kong FYS, Tull D, Worthington K, Chen MY, Huston WM, Timms P, McConville MJ, Fairley CK, Bradshaw CS, Tabrizi SN, Hocking JS.

PLoS One. 2017 May 12;12(5):e0177615. doi: 10.1371/journal.pone.0177615. eCollection 2017.

39.

Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium.

Murray GL, Bradshaw CS, Bissessor M, Danielewski J, Garland SM, Jensen JS, Fairley CK, Tabrizi SN.

Emerg Infect Dis. 2017 May;23(5):809-812. doi: 10.3201/eid2305.161745.

40.

Prospective Evaluation of ResistancePlus MG, a New Multiplex Quantitative PCR Assay for Detection of Mycoplasma genitalium and Macrolide Resistance.

Tabrizi SN, Su J, Bradshaw CS, Fairley CK, Walker S, Tan LY, Mokany E, Garland SM.

J Clin Microbiol. 2017 Jun;55(6):1915-1919. doi: 10.1128/JCM.02312-16. Epub 2017 Apr 5.

41.

Prevalence and predictors of unsatisfactory anal cytology tests in a cohort of gay and bisexual men in Sydney, Australia: baseline findings from the Study of the Prevention of Anal Cancer (SPANC).

Templeton DJ, Roberts JM, Poynten IM, Law C, Hillman RJ, Farnsworth A, Fairley CK, Tabrizi SN, Garland SM, Grulich AE, Jin F; SPANC Study Team.

Eur J Cancer Prev. 2017 May;26(3):212-216. doi: 10.1097/CEJ.0000000000000321.

PMID:
28350724
42.

The performance of human papillomavirus biomarkers in predicting anal high-grade squamous intraepithelial lesions in gay and bisexual men.

Jin F, Roberts JM, Grulich AE, Poynten IM, Machalek DA, Cornall A, Phillips S, Ekman D, McDonald RL, Hillman RJ, Templeton DJ, Farnsworth A, Garland SM, Fairley CK, Tabrizi SN; SPANC Research Team.

AIDS. 2017 Jun 1;31(9):1303-1311. doi: 10.1097/QAD.0000000000001462.

PMID:
28323757
43.

Microbial invasion of the amniotic cavity in midtrimester pregnancies using molecular microbiology.

Rowlands S, Danielewski JA, Tabrizi SN, Walker SP, Garland SM.

Am J Obstet Gynecol. 2017 Jul;217(1):71.e1-71.e5. doi: 10.1016/j.ajog.2017.02.051. Epub 2017 Mar 6.

PMID:
28268197
44.

The influence of sexual activity on the vaginal microbiota and Gardnerella vaginalis clade diversity in young women.

Vodstrcil LA, Twin J, Garland SM, Fairley CK, Hocking JS, Law MG, Plummer EL, Fethers KA, Chow EP, Tabrizi SN, Bradshaw CS.

PLoS One. 2017 Feb 24;12(2):e0171856. doi: 10.1371/journal.pone.0171856. eCollection 2017.

45.

A snapshot of Chlamydia trachomatis genetic diversity using multilocus sequence type analysis in an Australian metropolitan setting.

Danielewski JA, Phillips S, Kong FYS, Smith KS, Hocking JS, Guy R, Fairley CK, Garland SM, Tabrizi SN.

Eur J Clin Microbiol Infect Dis. 2017 Jul;36(7):1297-1303. doi: 10.1007/s10096-017-2935-6. Epub 2017 Feb 20.

PMID:
28220321
46.

Characterisation of microbial communities within aggressive prostate cancer tissues.

Yow MA, Tabrizi SN, Severi G, Bolton DM, Pedersen J; Australian Prostate Cancer BioResource, Giles GG, Southey MC.

Infect Agent Cancer. 2017 Jan 13;12:4. doi: 10.1186/s13027-016-0112-7. eCollection 2017.

47.

Molecular diagnosis of bacterial vaginosis: Does adjustment for total bacterial load or human cellular content improve diagnostic performance?

Plummer EL, Garland SM, Bradshaw CS, Law MG, Vodstrcil LA, Hocking JS, Fairley CK, Tabrizi SN.

J Microbiol Methods. 2017 Feb;133:66-68. doi: 10.1016/j.mimet.2016.12.024. Epub 2016 Dec 29.

PMID:
28042056
48.

Sustained Antibody Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent Human Papillomavirus (HPV) Vaccine in Adolescent Fijian Girls, and Subsequent Responses to a Single Dose of Bivalent HPV Vaccine: A Prospective Cohort Study.

Toh ZQ, Russell FM, Reyburn R, Fong J, Tuivaga E, Ratu T, Nguyen CD, Devi R, Kama M, Matanitobua S, Tabrizi SN, Garland SM, Sinha R, Frazer I, Tikoduadua L, Kado J, Rafai E, Mulholland EK, Licciardi PV.

Clin Infect Dis. 2017 Apr 1;64(7):852-859. doi: 10.1093/cid/ciw865.

PMID:
28034886
49.

Azithromycin 1.5g Over 5 Days Compared to 1g Single Dose in Urethral Mycoplasma genitalium: Impact on Treatment Outcome and Resistance.

Read TR, Fairley CK, Tabrizi SN, Bissessor M, Vodstrcil L, Chow EP, Grant M, Danielewski J, Garland SM, Hocking JS, Chen MY, Bradshaw CS.

Clin Infect Dis. 2017 Feb 1;64(3):250-256. doi: 10.1093/cid/ciw719. Epub 2016 Oct 24.

PMID:
28011607
50.

Genetic and Environmental Factors in Invasive Cervical Cancer: Design and Methods of a Classical Twin Study.

Machalek DA, Wark JD, Tabrizi SN, Hopper JL, Bui M, Dite GS, Cornall AM, Pitts M, Gertig D, Erbas B, Garland SM.

Twin Res Hum Genet. 2017 Feb;20(1):10-18. doi: 10.1017/thg.2016.93. Epub 2016 Dec 5.

PMID:
27917752

Supplemental Content

Loading ...
Support Center